Article
Central role for interleukin-2 in type 1 diabetes.
Diabetes - 1 Jan 2012
Hulme Maigan A, Wasserfall Clive H, Atkinson Mark A, Brusko Todd M
Abstract excerpt
Type 1 diabetes presents clinically with overt hyperglycemia resulting from progressive immune-mediated destruction of pancreatic β-cells and associated metabolic dysfunction. Combined genetic and immunological studies now highlight deficiencies in both the interleukin-2 (IL-2) receptor and its downstream signaling pathway as a central defect in the pathogenesis of type 1 diabetes. Prior intervention studies in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
